lncRNA PAN3-AS1 Modulates Cilium Assemble Signaling Pathway Through Regulation of RPGR as a Potential MS Diagnostic Biomarker: Integrated Systems Biology Investigation
- PMID: 40227518
- DOI: 10.1007/s12031-025-02331-w
lncRNA PAN3-AS1 Modulates Cilium Assemble Signaling Pathway Through Regulation of RPGR as a Potential MS Diagnostic Biomarker: Integrated Systems Biology Investigation
Abstract
Multiple sclerosis (MS), an autoimmune condition of the central nervous system (CNS), can lead to demyelination and axonal degeneration in the brain and spinal cord, which can cause progressive neurologic disability. MS symptoms include dysautonomia and progressive decline in motor abilities. In this investigation, we performed an integrated bioinformatics and experimental approach to find the expression level and interaction of a novel long non-coding RNA (lncRNA), PAN3-AS1, in MS samples. Microarray analysis was performed by R Studio using GEOquery and limma packages. lncRNA-mRNA RNA interaction analysis was performed using the lncRRIsearch database. Pathway enrichment analysis was performed by KEGG and Reactome online software through the Enrichr database. Protein-protein interaction analysis was performed by STRING online software. Gene ontology (GO) analysis was performed by Enrichr database. Based on microarray analysis, lncRNA PAN3-AS1 has a significantly low expression in MS samples compared to the control (logFC - 1.2, adj. P. Val 0.03). qRT-PCR results approved bioinformatics analyses. ROC analysis revealed that PAN3-AS1 could be considered a potential diagnostic biomarker of MS. Based on lncRNA-mRNA interaction analysis, lncRNA PAN3-AS1 regulates the expression level of RPGR. RPGR and its protein interactome regulate the cilium assembly, chaperon-mediated autophagy, and microarray biogenesis. lncRNA PAN3-AS1, as a significant low-expressed lncRNA in MS samples, could be a potential diagnostic MS biomarker. PAN3-AS1 might regulate the expression level of cilium assembly and chaperon-mediated autophagy. Dysregulation of PAN3-AS1 might affect the expression of RPGR and its protein interactome.
Keywords: Long non-coding RNA; Microarray analysis; Multiple sclerosis; Pathway enrichment.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: All the authors confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Competing Interests: The authors declare no competing interests.
Similar articles
-
The LncRNA STEAP3-AS1 promotes liver metastasis in colorectal cancer by regulating histone lactylation through chromatin remodelling.J Exp Clin Cancer Res. 2025 Jul 15;44(1):205. doi: 10.1186/s13046-025-03461-0. J Exp Clin Cancer Res. 2025. PMID: 40665344 Free PMC article.
-
Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8. Curr Neurol Neurosci Rep. 2025. PMID: 40591029 Review.
-
Role and mechanism of lncRNA ZEB1-AS1 endogenous competition for miR-365a-3p targeting NRF2 in ferroptosis in articular chondrocytes.J Mol Histol. 2025 Jun 7;56(3):190. doi: 10.1007/s10735-025-10450-2. J Mol Histol. 2025. PMID: 40481906
-
ADAMTS5 Modulates Breast Cancer Development as a Diagnostic Biomarker and Potential Tumour Suppressor, Regulated by BAIAP2-AS1, CRNDE and hsa-miR-135b-3p: Integrated Systems Biology and Experimental Approach.IET Syst Biol. 2025 Jan-Dec;19(1):e70015. doi: 10.1049/syb2.70015. IET Syst Biol. 2025. PMID: 40472834 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421. https://doi.org/10.1016/s0197-4580(00)00124-x - DOI - PubMed - PMC
-
- Andrade-Tomaz M, de Souza I, Rocha CRR, Gomes LR (2020) The role of chaperone-mediated autophagy in cell cycle control and its implications in cancer. Cells 9:2140. https://doi.org/10.3390/CELLS9092140 - DOI - PubMed - PMC
-
- Baldassari LE, Feng J, Clayton BLL et al (2019) Developing therapeutic strategies to promote myelin repair in multiple sclerosis. Expert Rev Neurother 19(10):997–1013. https://doi.org/10.1080/14737175.2019.1632192 - DOI - PubMed
-
- Barani A, Fanavari Z, Beikverdi K et al (2022) Transcription analysis of the THBS2 gene through regulation by potential non-coding diagnostic biomarkers and oncogenes of gastric cancer in the ECM receptor interaction signaling pathway: integrated systems biology and experimental investigation. https://doi.org/10.21203/rs.3.rs-2285590/v2
-
- Bravo GÁ, Cedeño RR, Casadevall MP, Ramió-Torrentà L (2022) Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells 11(13):2058. https://doi.org/10.3390/cells11132058 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical